A longitudinal study of serotonergic function in depression

Neuropsychopharmacology

Volumn 26, Issue 5, 2002, Pages 653-659

  Golden, Robert N ^a   Heine, Amy Durr ^a   Ekstrom, R David ^a   Bebchuk, Joseph M ^a   Leatherman, Martha E ^a   Garbutt, James C ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Dorothea Dix Hospital   (United States)

Author keywords

Challenge test; Clomipramine; Depression; Desipramine; Prolactin; Serotonin

Indexed keywords

CLOMIPRAMINE; DESIPRAMINE; PROLACTIN;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG RESPONSE; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; PRIORITY JOURNAL; REMISSION; SEROTONINERGIC SYSTEM;

ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; AREA UNDER CURVE; CLOMIPRAMINE; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROLACTIN; SEROTONIN;

EID: 0036201162     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(01)00406-7     Document Type: Article

References (34)

1. Decreased 5-HT-mediated prolactin release in major depression
2. Neuroendocrine responses to m-chlorophenylpiperazine and l-tryptophan in bulimia
3. Serotonin function and the mechanisms of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan
4. Recovery from major depression is not associated with normalization of serotonergic function
5. Altered prolactin response to clomipramine rechallenge in healthy volunteers
6. Neuroendocrine effects of intravenous clomipramine in depressed patients and healthy subjects
7. Antidepressant challenge tests: The interface of pharmacokinetics and pharmacodynamics
8. The effects of age, gender, and season on serotonergic function in healthy subjects
9. Abnormal neuroendocrine responsivity to acute intravenous clomipramine challenge in depressed patients
10. The effects of intravenous clomipramine on neurohormones in healthy subjects
11. Effects of desipramine on 5-HT function in depressed patients and healthy subjects
12. The effects of 5-HT3 receptor blockade on the psychobiological response to clomipramine challenge
13. Abnormal neuroendocrine responsivity to clomipramine in depression
14. Seasonal effects in prolactin response to m-chlorophenylpiperazine challenge in obsessive-compulsive disorder
15. A rating scale for depression
16. Citalopram-pharmacologic profile of a specific serotonin uptake inhibitor with antidepressant activity
17. Multiple hormone responses to stimulation with dl-fenfluramine in patients with major depression before and after antidepressive treatment
18. Prolactin and antidepressants
19. Central serotonergic changes following antidepressant treatment: A neuroendocrine assessment
20. The serotonin hypothesis of major depression
21. Fluoxetine, but not tricyclic antidepressants, potentiates the 5-hydroxytryptophan-mediated increase in plasma cortisol and prolactin secretion in subjects with major de- pression or with obsessive-compulsive disorder
22. Seasonal variation in plasma prolactin response to d-fenfluramine in healthy subjects
23. Effect of diet on urinary MHPG excretion in depressed patients and in normal controls
24. Comparison of clomipramine and fenfluramine challenges
25. D-fenfluramine-induced prolactin and cortisol release in major depression: Response to treatment
26. Prolactin response to fenfluramine and placebo challenge following maintenance pharmacotherapy withdrawal in remitted depressed patients
27. Enhanced serotonergic responsivity following electroconvulsive therapy in patients with major depression
28. Effect of imipramine treatment on the prolactin response to fenfluramine and placebo challenge in depressed patients
29. Liquid-chromatographic determination of eight tri- and tetracyclic antidepressants and their major active metabolites
30. Serotonergic stimulation of prolactin and corticosterone secretion is mediated by different pathways from the mediobasal hypothalamus
31. Hormonal probes of central serotonergic activity: Do they really exist?